SELLAS Life Sciences (SLS) Tax Provisions (2013 - 2019)

SELLAS Life Sciences (SLS) has 4 years of Tax Provisions data on file, last reported at -$81000.0 in Q4 2019.

• On a quarterly basis, Tax Provisions rose 94.74% year-over-year to -$81000.0 in Q4 2019; TTM through Dec 2019 was -$1.6 million, a 24.29% decrease from a year earlier, with the FY2021 full-year figure at -$237000.0, down 1294.12% from the prior year.
• Tax Provisions for Q4 2019 stood at -$81000.0, up from -$1.5 million in the prior quarter.
• Over the last five years, Tax Provisions for SLS reached as high as $163000.0 in Q2 2018 and fell as low as -$1.5 million in Q4 2018.
• Historically, Tax Provisions has averaged -$201000.0 across 3 years, with a median of $68000.0 in 2017.
• Across the five-year window, Tax Provisions plunged 2210.96% in 2018 and surged 94.74% in 2019, its largest moves.
• Year by year, Tax Provisions stood at $73000.0 in 2017, then plunged by 2210.96% to -$1.5 million in 2018, then jumped by 94.74% to -$81000.0 in 2019.
• Per Business Quant data, the three most recent Tax Provisions figures were -$81000.0 in Q4 2019, -$1.5 million in Q4 2018, and $163000.0 in Q2 2018.